Industry Insights
-
Cancer Treatment: Advances In The 20th And 21st Centuries
4/29/2024
This exploration not only illuminates the remarkable strides made in combating cancer but also underscores the pivotal role of cutting-edge technologies in shaping the trajectory of oncological care.
-
6 Decades Of Impact: DIA’s Global Journey
4/29/2024
By embracing its foundational pillars, learn how DIA continues to address ongoing challenges in drug information and healthcare as it enters its seventh decade in the industry.
-
What Can Digital Patient Twins Do For Clinical Research?
4/29/2024
Digital patient twins have the potential to vastly improve our current healthcare systems by offering personalized therapeutics, enhanced health monitoring, and streamlined pharmaceutical manufacturing, including clinical trials.
-
The Relevance Of ePROs In Early Phase Clinical Trials
4/26/2024
Examine how integrating electronic Patient Reported Outcomes (ePROs) in early clinical research not only enhances understanding of the drug's effects but also amplifies its market value.
-
Fortifying The 3 Cs With Strategic Approaches And Tools
4/25/2024
In part two of this series, the authors continue the discussion by identifying specific tools and strategies that companies can use to improve communication and collaboration.
-
Assessing The 3Cs: Does Your Organization Have The Foundation For Clinical Trial Success?
4/25/2024
In part one of this series on exploring the importance of culture, communication, and collaboration, the authors discuss the makings of a strong company foundation and offer an assessment plan meant to reveal strengths and weaknesses in those three areas.
-
Validating A Better ALS Biomarker With Coya’s Fred Grossman
4/24/2024
Coya Therapeutics President and CMO Fred Grossman, DO, FAPA discusses a potential new biomarker for ALS — 4-HNE, an oxidative stress biomarker — and how it could be more effective than the current standard, NfL.
-
For Veteran PI, Research Requires Motivation, Dedication, And CRO Support
4/23/2024
Principal investigator Dr. Luke Twelves discusses how he remained motivated to continue conducting trials and shares insights into what he thinks will inspire others to do the same.
-
Will Today’s Clinical Trial Trends Become Tomorrow’s Routine?
4/23/2024
Clinical trial trends can be divided into two groups — those related to changes in the conduct of clinical trials and those related to the changes in therapeutic areas. Will these trends hold steady as 2024 unfolds?
-
4 Ways Concomitant Medications Can Complicate Your Trial
4/22/2024
Concomitant medications (con-meds) significantly influence clinical trials, affecting duration, costs, and participant safety. However, they are often inadequately tracked and analyzed in studies.